Randall Lanier
- Virology top 1%
- Epidemiology top 10%
- Infectious Diseases top 5%
- Molecular Biology
- Genetics
- Co-authors
- George R. PainterAlice RobertsonScott A. FosterScott ParkerBernhard LampertWendy PainterR. Mark L. BullerMichael R. Betts
- Topics
- HIV/AIDS drug development and treatment (12 papers)HIV Research and Treatment (11 papers)Herpesvirus Infections and Treatments (9 papers)
- Journals
- BloodNeurologyCancer Research
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Randall Lanier
29 papers receiving 789 citations
Peers
Comparison fields: 5 of 61
- Virology 467
- Epidemiology 452
- Infectious Diseases 347
- Molecular Biology 259
- Genetics 168
Countries citing papers authored by Randall Lanier
This map shows the geographic impact of Randall Lanier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall Lanier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall Lanier more than expected).
Fields of papers citing papers by Randall Lanier
This network shows the impact of papers produced by Randall Lanier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall Lanier. The network helps show where Randall Lanier may publish in the future.
Co-authorship network of co-authors of Randall Lanier
This figure shows the co-authorship network connecting the top 25 collaborators of Randall Lanier. A scholar is included among the top collaborators of Randall Lanier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall Lanier. Randall Lanier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 13 | |
| 3 | 14 | |
| 4 | 35 | |
| 5 | 42 | |
| 6 | 36 | |
| 7 | 0 | |
| 8 | 123 | |
| 9 | 5 | |
| 10 | 56 | |
| 11 | 9 | |
| 12 | 1 | |
| 13 | 7 | |
| 14 | 41 | |
| 15 | 22 | |
| 16 | Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001. | 21 |
| 17 | 12 | |
| 18 | 45 | |
| 19 | 20 | |
| 20 | 74 |
About Randall Lanier
Randall Lanier is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 31 papers that have together received 814 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (11 papers) and Herpesvirus Infections and Treatments (9 papers). The work is most often cited by research in Virology (467 citations), Infectious Diseases (347 citations) and Epidemiology (452 citations). Randall Lanier has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include George R. Painter, Alice Robertson, Scott A. Foster, Scott Parker, Bernhard Lampert, Wendy Painter, R. Mark L. Buller, Michael R. Betts, Thomas Melby and Lawrence C. Trost. Their work appears in journals such as Blood, Neurology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.